Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA 2004 Reg Agenda Includes CFC Albuterol Phase Out, Final Label Rule

Jan 05 2004

• By The Pink Sheet

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

Related Content

FDA Drug Safety Rule Would Promote Premarketing Adverse Event Reports

Mar 17 2003

FDA Bar Code Proposal Requires NDC; Lot, Expiration Date Not Cost Effective

Mar 17 2003

CFC Albuterol Inhaler Phase-Out Urged By Nine Groups In Citizen Petition

Mar 03 2003

FDA Defends Efficacy Standard In Response To WLF Suit

Nov 10 2003

FDA PROPOSED PHYSICIAN LABELING REVISIONS WILL BE TESTED WITH 480 MDs: PUBLIC WORKSHOP ON LABELING CHANGES MAY BE CONVENED BY AGENCY THIS SUMMER

May 15 1995

FDA Investor Relations: SEC Agreement Close, “Complete Response” Reg Not

Jan 05 2004

FDA Drug Approval Time Edges Up To 18.5 Months In 2001

Jan 07 2002

Indication, Warning Summaries In Labeling "Highlights" - FDA Rule

Jan 01 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window